GPT Healthcare LimitedGPTHEALTHCorporate

Healthcare Latest results: Dec 2025 4 quarters of data

₹140.74

MCap ₹1,155 Cr

GPT Healthcare Limited — Stock analysis & AI research GPT Healthcare Limited — Multibagger AI analysis GPT Healthcare Limited — Seasonality — best & worst months GPT Healthcare Limited — Technical setup — score, trend, support & resistance GPT Healthcare Limited — Live exchange announcements

📋 High ROCE Stocks 📋 Stocks Cheaper Than Their Industry 📋 Stocks With Strong Quarterly Results 📋 High Promoter Holding Stocks 🏭 Healthcare sector

AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.

₹120 Cr

Sales · Dec 2025

+17.6% YoY

₹21 Cr

Operating Profit · Dec 2025

-2.6% YoY

17.2%

OPM % · Dec 2025

-17.3% YoY

₹9 Cr

Net Profit · Dec 2025

-23.5% YoY

₹1.14

EPS · Dec 2025

-23.5% YoY

📝 GPT Healthcare Limited — results explained

Quarter ended December 2025 (Q3 FY26)

GPT Healthcare Limited reported revenue of ₹120 crore for the quarter ended December 2025 (Q3 FY26), up 17.6% from ₹102 crore in the same quarter last year.

Net profit fell 23.5% year-on-year to ₹9 crore, from ₹12 crore. Earnings per share (EPS) came in at ₹1.14.

Operating profit stood at ₹21 crore — an operating margin (OPM) of 17.2%, compared with 20.8% in the year-ago quarter.

Valuation snapshot

At the current price of ₹140.74, GPTHEALTH has a market capitalisation of ₹1,155 crore.

Within the Healthcare industry, it is the 12th-largest of the 22 companies we track by market value.

Shareholding pattern

As of Jun 2026, promoters held 65.57%, foreign institutional investors (FIIs) 3.03%, domestic institutional investors (DIIs) 6.94%, public shareholders 24.46% of GPT Healthcare Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close

Valuation

Market Cap ?

₹1,155 Cr

Current Price ?

₹140.7

P/E ?

N/A

Industry P/E ?

34.70

P/B ?

4.29

P/S ?

N/A

P/FCF ?

28.87

Enterprise Value ?

₹1,246 Cr

EV/EBITDA ?

N/A

PEG ?

N/A

Earnings Yield ?

N/A

Dividend Yield ?

1.76%

Profitability & Returns

Sales (TTM) ?

N/A

OPM ?

N/A

Profit after tax (TTM) ?

N/A

EPS (TTM) ?

N/A

ROCE ?

20.0%

ROE ?

N/A

ROA ?

N/A

Growth

Sales — latest qtr ?

₹120 Cr

PAT — latest qtr ?

₹9 Cr

YoY qtr sales growth ?

17.6%

YoY qtr profit growth ?

-23.5%

Sales growth (3y) ?

N/A

Sales growth (5y) ?

N/A

Profit growth (3y) ?

N/A

Profit growth (5y) ?

N/A

Financial Health

Debt ?

₹91 Cr

Debt to Equity ?

0.34

Interest Coverage ?

N/A

Current Ratio ?

N/A

Ownership

Promoter holding ?

65.57%

Change in promoter holding ?

0.00%

Pledged percentage ?

N/A

Market

Return 3 months ?

-7.7%

Return 6 months ?

2.4%

🗓️ Quarterly results (4 quarters · ₹ Cr)

same fiscal quarter as Dec bestweakest per row · for costs (interest, NPAs) low is best Highlight

Metric	Mar 2024	Dec 2024	Jun 2025	Dec 2025	YoY %	QoQ %
Sales	99	102	107	120	+17.6%	—
Operating Profit	23	21	17	21	-2.6%	—
Other Income	2	2	2	1	-24.4%	—
Interest	2	1	2	2	+164.9%	—
Depreciation	5	5	6	7	+52.3%	—
Profit Before Tax	18	18	11	13	-27.6%	—
Net Profit	13	12	8	9	-23.5%	—
EPS	1.59	1.49	0.94	1.14	-23.5%	—
OPM %	23.3%	20.8%	16.2%	17.2%	-17.3%	—

📆 Annual results (₹ Cr, FY = Apr–Mar)

Annual rollup not yet available We need at least 3 quarters of a fiscal year to compute annual figures. This symbol does not yet have a complete fiscal year in our database.

🏛️ Balance Sheet (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Equity Capital	80	82	82	82	+0.0%
Reserves	85	136	166	187	+12.7%
Borrowings	82	31	35	91	+160.0%
Other Liabilities	79	96	101	104	+3.0%
Total Liabilities	327	346	384	465	+21.1%
Fixed Assets	228	224	228	342	+50.0%
CWIP	3	6	46	1	-97.8%
Investments	13	30	32	43	+34.4%
Other Assets	83	85	78	79	+1.3%
Total Assets	327	346	384	465	+21.1%

💧 Cash Flow (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Cash from Operating Activity	66	69	67	81	+20.9%
Cash from Investing Activity	5	-25	-33	-47	-42.4%
Cash from Financing Activity	-73	-48	-35	-31	+11.4%
Net Cash Flow	-2	-5	-0	2	—
Free Cash Flow	58	50	18	40	+122.2%
CFO/OP	103%	95%	101%	112%	+10.9%

➗ Ratios (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Debtor Days	21	22	18	16	-11.1%
Inventory Days	43	36	41	43	+4.9%
Days Payable	161	165	161	170	+5.6%
Cash Conversion Cycle	-97	-106	-102	-112	-9.8%
Working Capital Days	-18	-16	-28	4	+114.3%
ROCE %	25%	30%	27%	20%	-25.9%

👥 Shareholding (latest 5 periods)

Metric	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	% Chg
Promoters	65.57%	65.57%	65.57%	65.57%	65.57%	+0.0%
FIIs	4.96%	3.20%	2.73%	2.81%	3.03%	+7.8%
DIIs	9.33%	6.45%	6.20%	6.84%	6.94%	+1.5%
Public	20.14%	24.77%	25.48%	24.79%	24.46%	-1.3%
No. of Shareholders	67,060	67,617	66,626	64,075	62,454	-2.5%

⚖️ Peer comparison

Industry: Healthcare · 22 companies · full page →

#	Company	CMP	MCap (Cr)	P/E	Sales TTM	NP TTM	OPM%	NPM%	Sales YoY%	NP YoY%	Qtr Rev Δ%	Qtr NP Δ%
1	VIJAYA Vijaya Diagnostic	₹1,507.80	15,530	82.7	857	187	42.3%	21.8%	19.5%	20.2%	22.8%	37.3%
2	METROPOLIS Metropolis Healthcare	₹596.30	12,370	61.1	1,710	203	24.7%	11.9%	23.6%	31.4%	16.6%	25.7%
3	HCG Healthcare Global	₹704.05	10,512	390.9	2,626	33	18.2%	1.3%	14.6%	-53.3%	13.1%	175.3%
4	YATHARTH Yatharth Hospital	₹988.90	9,528	54.1	1,200	171	23.6%	14.3%	36.2%	31.6%	47.6%	16.2%
5	JLHL Jupiter Life	₹277.85	9,109	9.7	1,557	187	22.1%	12.0%	20.9%	-6.7%	18.2%	-14.5%
6	THYROCARE Thyrocare Technologies	₹555.45	8,841	50.0	876	176	32.1%	20.1%	20.8%	79.4%	24.3%	33.2%
7	KOVAI Kovai Medical	₹6,260.50	6,850	26.7	1,644	256	27.9%	15.6%	15.7%	16.7%	15.3%	20.6%
8	INDRAMEDCO Indraprastha Medical	₹363.20	3,330	17.7	1,524	188	18.0%	12.4%	9.3%	13.7%	11.3%	9.5%
9	KRSNAA Krsnaa Diagnostics	₹543.40	1,763	18.1	816	98	26.8%	12.0%	7.8%	31.0%	22.1%	-19.3%
10	SURAKSHA Suraksha Diagnostic	₹311.85	1,624	45.3	325	35	31.4%	10.8%	23.1%	1.4%	20.7%	40.0%
11	SHALBY Shalby	₹132.15	1,418	38.0	1,176	37	12.1%	3.2%	5.0%	1683.0%	11.7%	36.7%
12	GPTHEALTH GPT Healthcare	₹157.90	1,296	27.4	491	48	18.5%	9.8%	15.1%	-21.9%	17.8%	62.5%
13	LAXMIDENTL Laxmi Dental	₹196.21	1,080	35.0	287	31	16.2%	10.9%	16.0%	-10.1%	13.2%	28.9%
14	NEPHROCARE Nephro Care	₹234.80	387	—	—	—	—	—	—	—	68.4%	347.7%
15	LOTUSEYE Lotus Eye	₹114.50	243	n/m	57	0	8.5%	0.3%	8.4%	-89.1%	26.2%	13.0%
16	UNIHEALTH Unihealth Hospitals	₹121.00	190	6.5	132	46	40.9%	34.8%	—	—	104.6%	71.5%
17	MADHAVBAUG Vaidya Sane	₹148.00	156	19.1	147	8	11.4%	5.6%	—	—	116.1%	94.3%
18	MHHL Mohini Health	₹57.05	104	—	145	-17	-1.4%	-11.7%	—	—	-6.6%	-1400.0%
19	MAITREYA Maitreya Medicare	₹120.65	82	—	45	-2	-1.0%	-5.5%	—	—	-5.2%	-1720.0%
20	AATMAJ Aatmaj Healthcare	₹26.75	60	83.6	24	1	9.7%	2.9%	—	—	22.5%	-39.4%
21	NIDAN Nidan Laborator.	₹33.00	46	30.6	26	2	19.0%	5.9%	—	—	-11.2%	-92.0%
22	ARTEMISMED Artemis Medicare	₹315.00	—	48.0	1,081	103	17.4%	9.6%	15.4%	25.9%	16.3%	30.9%

❓ Frequently asked questions

What was GPT Healthcare Limited's revenue in Q3 FY26?